These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12359360)

  • 1. Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway.
    Jeong SJ; Itokawa T; Shibuya M; Kuwano M; Ono M; Higuchi R; Miyamoto T
    Cancer Lett; 2002 Dec; 187(1-2):129-33. PubMed ID: 12359360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
    Chou MT; Wang J; Fujita DJ
    BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.
    Kojima-Yuasa A; Hua JJ; Kennedy DO; Matsui-Yuasa I
    Life Sci; 2003 Jul; 73(10):1299-313. PubMed ID: 12850245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
    Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
    J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Isaac J; Yi H; Andoh TF
    Kidney Int; 2002 Aug; 62(2):422-33. PubMed ID: 12110003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.
    Zhang H; Wu J; Meng L; Shou CC
    World J Gastroenterol; 2002 Dec; 8(6):994-8. PubMed ID: 12439912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
    Itokawa T; Nokihara H; Nishioka Y; Sone S; Iwamoto Y; Yamada Y; Cherrington J; McMahon G; Shibuya M; Kuwano M; Ono M
    Mol Cancer Ther; 2002 Mar; 1(5):295-302. PubMed ID: 12489845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors.
    Yang S; Toy K; Ingle G; Zlot C; Williams PM; Fuh G; Li B; de Vos A; Gerritsen ME
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1797-803. PubMed ID: 12426207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
    Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of inflammatory corneal angiogenesis by TNP-470.
    Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
    Chen HH; Zhou HJ; Wu GD; Lou XE
    Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
    Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
    Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
    Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
    Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model.
    Zhang W; Ran S; Sambade M; Huang X; Thorpe PE
    Angiogenesis; 2002; 5(1-2):35-44. PubMed ID: 12549858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.